How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in Q1 2021?

1 institutional investor reported RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

Q: What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock used to aggregate holder disclosures.

CUSIP: 75629V104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Class A Common Stock
Shares outstanding: 514,715,255
Total 13F shares: 30
Share change: 0
Total reported value: $1,000
Price per share: $33.33
Number of holders: 1

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 75629V104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CWM, LLC	13F	Company	0%	30	$1,000	—	31 Dec 2020	13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q1 2021

As of 31 Mar 2021, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 30 shares. The largest 1 holders included CWM, LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.